{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:06:29Z","timestamp":1784639189112,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"DOI":"10.1007\/s13304-026-02773-w","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:00:31Z","timestamp":1784638831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Additive value of oncological resectability criteria for predicting post-hepatectomy liver failure in hepatocellular carcinoma"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9242-8666","authenticated-orcid":false,"given":"Shinichi","family":"Ikuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimitsu","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"2773_CR1","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1245\/s10434-020-08239-6","volume":"27","author":"JY Liu","year":"2020","unstructured":"Liu JY, Ellis RJ, Hu QL et al (2020) Post hepatectomy liver failure risk calculator for preoperative and early postoperative period following major hepatectomy. Ann Surg Oncol 27:2868\u20132876. https:\/\/doi.org\/10.1245\/s10434-020-08239-6","journal-title":"Ann Surg Oncol"},{"key":"2773_CR2","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.12998\/wjcc.v9.i8.1793","volume":"9","author":"Y Xing","year":"2021","unstructured":"Xing Y, Liu ZR, Yu W, Zhang HY, Song MM (2021) Risk factors for post-hepatectomy liver failure in 80 patients. World J Clin Cases 9:1793\u20131802. https:\/\/doi.org\/10.12998\/wjcc.v9.i8.1793","journal-title":"World J Clin Cases"},{"key":"2773_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.14701\/ahbps.2018.22.3.185","volume":"22","author":"KM Chin","year":"2018","unstructured":"Chin KM, Allen JC, Teo JY et al (2018) Predictors of post-hepatectomy liver failure in patients undergoing extensive liver resections for hepatocellular carcinoma. Ann Hepatobiliary Pancreat Surg 22:185\u2013196. https:\/\/doi.org\/10.14701\/ahbps.2018.22.3.185","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"2773_CR4","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s13304-020-00859-7","volume":"72","author":"F Tomassini","year":"2020","unstructured":"Tomassini F, Giglio MC, De Simone G, Montalti R, Troisi RI (2020) Hepatic function assessment to predict post-hepatectomy liver failure: what can we trust? A systematic review. Updates Surg 72:925\u2013938. https:\/\/doi.org\/10.1007\/s13304-020-00859-7","journal-title":"Updates Surg"},{"key":"2773_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s13244-017-0558-1","volume":"8","author":"A Gotra","year":"2017","unstructured":"Gotra A, Sivakumaran L, Chartrand G et al (2017) Liver segmentation: indications, techniques and future directions. Insights Imaging 8:377\u2013392. https:\/\/doi.org\/10.1007\/s13244-017-0558-1","journal-title":"Insights Imaging"},{"key":"2773_CR6","doi-asserted-by":"publisher","first-page":"15469","DOI":"10.1038\/s41598-025-97878-4","volume":"15","author":"T Tang","year":"2025","unstructured":"Tang T, Guo T, Zhu B, Tian Q, Wu Y, Liu Y (2025) Interpretable machine learning model for predicting post-hepatectomy liver failure in hepatocellular carcinoma. Sci Rep 15:15469. https:\/\/doi.org\/10.1038\/s41598-025-97878-4","journal-title":"Sci Rep"},{"key":"2773_CR7","doi-asserted-by":"publisher","first-page":"109462","DOI":"10.1016\/j.ejso.2024.109462","volume":"51","author":"S Famularo","year":"2025","unstructured":"Famularo S, Maino C, Milana F et al (2025) Preoperative prediction of post hepatectomy liver failure after surgery for hepatocellular carcinoma on CT-scan by machine learning and radiomics analyses. Eur J Surg Oncol 51:109462. https:\/\/doi.org\/10.1016\/j.ejso.2024.109462","journal-title":"Eur J Surg Oncol"},{"key":"2773_CR8","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig M, Forner A, Rimola J et al (2022) BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol 76:681\u2013693. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.018","journal-title":"J Hepatol"},{"key":"2773_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","volume":"82","author":"European Association for the Study of the Liver","year":"2025","unstructured":"European Association for the Study of the Liver (2025) EASL clinical practice guidelines on the management of hepatocellular carcinoma. J Hepatol 82:315\u2013374. https:\/\/doi.org\/10.1016\/j.jhep.2024.08.028","journal-title":"J Hepatol"},{"key":"2773_CR10","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","volume":"78","author":"AG Singal","year":"2023","unstructured":"Singal AG, Llovet JM, Yarchoan M et al (2023) AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology 78:1922\u20131965. https:\/\/doi.org\/10.1097\/HEP.0000000000000466","journal-title":"Hepatology"},{"key":"2773_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/hepr.13892","volume":"53","author":"K Hasegawa","year":"2023","unstructured":"Hasegawa K, Takemura N, Yamashita T et al (2023) Clinical practice guidelines for hepatocellular carcinoma: the Japan society of hepatology 2021 version (5th JSH-HCC Guidelines). Hepatol Res 53:383\u2013390. https:\/\/doi.org\/10.1111\/hepr.13892","journal-title":"Hepatol Res"},{"key":"2773_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000514174","volume":"10","author":"M Kudo","year":"2021","unstructured":"Kudo M, Kawamura Y, Hasegawa K et al (2021) Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 update. Liver Cancer 10:181\u2013223. https:\/\/doi.org\/10.1159\/000514174","journal-title":"Liver Cancer"},{"key":"2773_CR13","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1159\/000538627","volume":"13","author":"K Akahoshi","year":"2024","unstructured":"Akahoshi K, Shindoh J, Tanabe M et al (2024) Oncological resectability criteria for hepatocellular carcinoma in the era of novel systemic therapies: the Japan liver cancer association and japanese society of hepato-biliary-pancreatic surgery expert consensus statement 2023. Liver Cancer 13:0\u201310. https:\/\/doi.org\/10.1159\/000538627","journal-title":"Liver Cancer"},{"key":"2773_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1159\/000539381","volume":"13","author":"J Shindoh","year":"2024","unstructured":"Shindoh J, Kawamura Y, Akahoshi K et al (2024) Clinical utility of the novel oncological criteria of resectability for advanced hepatocellular carcinoma. Liver Cancer 13:601\u2013609. https:\/\/doi.org\/10.1159\/000539381","journal-title":"Liver Cancer"},{"key":"2773_CR15","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s10147-025-02840-z","volume":"30","author":"N Iseda","year":"2025","unstructured":"Iseda N, Itoh S, Ninomiya M et al (2025) Survival impact and recurrence prediction using oncologic resectability classification in hepatocellular carcinoma following hepatic resection: a Japanese multi-center study. Int J Clin Oncol 30:2063\u20132071. https:\/\/doi.org\/10.1007\/s10147-025-02840-z","journal-title":"Int J Clin Oncol"},{"key":"2773_CR16","doi-asserted-by":"publisher","first-page":"5260","DOI":"10.7150\/jca.58726","volume":"12","author":"G Guo","year":"2021","unstructured":"Guo G, Lei Z, Tang X et al (2021) External validation of six liver functional reserve models to predict posthepatectomy liver failure after major resection for hepatocellular carcinoma. J Cancer 12:5260\u20135267. https:\/\/doi.org\/10.7150\/jca.58726","journal-title":"J Cancer"},{"key":"2773_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693\u2013699. https:\/\/doi.org\/10.1056\/NEJM199603143341104","journal-title":"N Engl J Med"},{"key":"2773_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","volume":"10","author":"V Mazzaferro","year":"2009","unstructured":"Mazzaferro V, Llovet JM, Miceli R et al (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35\u201343. https:\/\/doi.org\/10.1016\/S1470-2045(08)70284-5","journal-title":"Lancet Oncol"},{"key":"2773_CR19","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/bjs.11464","volume":"107","author":"DI Tsilimigras","year":"2020","unstructured":"Tsilimigras DI, Moris D, Hyer JM et al (2020) Hepatocellular carcinoma tumour burden score to stratify prognosis after resection. Br J Surg 107:854\u2013864. https:\/\/doi.org\/10.1002\/bjs.11464","journal-title":"Br J Surg"},{"key":"2773_CR20","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.surg.2010.10.001","volume":"149","author":"NN Rahbari","year":"2011","unstructured":"Rahbari NN, Garden OJ, Padbury R et al (2011) Posthepatectomy liver failure: a definition and grading by the international study group of liver surgery (ISGLS). Surgery 149:713\u2013724. https:\/\/doi.org\/10.1016\/j.surg.2010.10.001","journal-title":"Surgery"},{"key":"2773_CR21","doi-asserted-by":"publisher","first-page":"dju041","DOI":"10.1093\/jnci\/dju041","volume":"106","author":"MS Pepe","year":"2014","unstructured":"Pepe MS, Janes H, Li CI (2014) Net risk reclassification p values: valid or misleading? J Natl Cancer Inst 106:dju041. https:\/\/doi.org\/10.1093\/jnci\/dju041","journal-title":"J Natl Cancer Inst"},{"key":"2773_CR22","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1007\/s11605-022-05451-5","volume":"26","author":"L Alaimo","year":"2022","unstructured":"Alaimo L, Endo Y, Lima HA et al (2022) A comprehensive preoperative predictive score for post-hepatectomy liver failure after hepatocellular carcinoma resection based on patient comorbidities, tumor burden, and liver function: the CTF score. J Gastrointest Surg 26:2486\u20132495. https:\/\/doi.org\/10.1007\/s11605-022-05451-5","journal-title":"J Gastrointest Surg"},{"key":"2773_CR23","doi-asserted-by":"publisher","first-page":"605296","DOI":"10.3389\/fonc.2021.605296","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Liu Z, Mo Y et al (2021) Prediction of post-hepatectomy liver failure in patients with hepatocellular carcinoma based on radiomics using Gd-EOB-DTPA-enhanced MRI: the liver failure model. Front Oncol 11:605296. https:\/\/doi.org\/10.3389\/fonc.2021.605296","journal-title":"Front Oncol"},{"key":"2773_CR24","doi-asserted-by":"publisher","first-page":"100744","DOI":"10.1016\/j.aohep.2022.100744","volume":"27","author":"YR Li","year":"2022","unstructured":"Li YR, Chen JD, Huang J, Wu FX, Jin GZ (2022) Post-hepatectomy liver failure prediction and prevention: development of a nomogram containing postoperative anticoagulants as a risk factor. Ann Hepatol 27:100744. https:\/\/doi.org\/10.1016\/j.aohep.2022.100744","journal-title":"Ann Hepatol"},{"key":"2773_CR25","doi-asserted-by":"publisher","first-page":"9112","DOI":"10.3390\/ijms24119112","volume":"24","author":"S Rodimova","year":"2023","unstructured":"Rodimova S, Mozherov A, Elagin V et al (2023) Effect of hepatic pathology on liver regeneration: the main metabolic mechanisms causing impaired hepatic regeneration. Int J Mol Sci 24:9112. https:\/\/doi.org\/10.3390\/ijms24119112","journal-title":"Int J Mol Sci"},{"key":"2773_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41392-024-02104-8","volume":"10","author":"X Ma","year":"2025","unstructured":"Ma X, Huang T, Chen X et al (2025) Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics. Signal Transduct Target Ther 10:63. https:\/\/doi.org\/10.1038\/s41392-024-02104-8","journal-title":"Signal Transduct Target Ther"},{"key":"2773_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/cr.2010.183","volume":"21","author":"G He","year":"2011","unstructured":"He G, Karin M (2011) NF-\u03baB and STAT3\u2014key players in liver inflammation and cancer. Cell Res 21:159\u2013168. https:\/\/doi.org\/10.1038\/cr.2010.183","journal-title":"Cell Res"},{"key":"2773_CR28","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/hep.23430","volume":"51","author":"H Wang","year":"2010","unstructured":"Wang H, Park O, Lafdil F et al (2010) Interplay of hepatic and myeloid signal transducer and activator of transcription 3 in facilitating liver regeneration via tempering innate immunity. Hepatology 51:1354\u20131362. https:\/\/doi.org\/10.1002\/hep.23430","journal-title":"Hepatology"},{"key":"2773_CR29","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jhep.2019.06.003","volume":"71","author":"M Prodeau","year":"2019","unstructured":"Prodeau M, Drumez E, Duhamel A et al (2019) An ordinal model to predict the risk of symptomatic liver failure in patients with cirrhosis undergoing hepatectomy. J Hepatol 71:920\u2013929. https:\/\/doi.org\/10.1016\/j.jhep.2019.06.003","journal-title":"J Hepatol"},{"key":"2773_CR30","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s12072-025-10781-y","volume":"19","author":"S Shimose","year":"2025","unstructured":"Shimose S, Saeki I, Ito T et al (2025) The benefit of conversion therapy for patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab using newly established oncological resectability criteria in Japan. Hepatol Int 19:846\u2013855. https:\/\/doi.org\/10.1007\/s12072-025-10781-y","journal-title":"Hepatol Int"},{"key":"2773_CR31","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1186\/s12885-024-12772-y","volume":"24","author":"H Xu","year":"2024","unstructured":"Xu H, Zhang H, Li B, Chen K, Wei Y (2024) Systemic conversion therapies for initially unresectable hepatocellular carcinoma: a systematic review and meta-analysis. BMC Cancer 24:1008. https:\/\/doi.org\/10.1186\/s12885-024-12772-y","journal-title":"BMC Cancer"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-026-02773-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-026-02773-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-026-02773-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:00:31Z","timestamp":1784638831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-026-02773-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":31,"alternative-id":["2773"],"URL":"https:\/\/doi.org\/10.1007\/s13304-026-02773-w","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Ethics Committee (approval no.: 2025-30) and adhered to the Declaration of Helsinki. Patient consent was waived due to the retrospective design and use of de-identified data.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}